Fuhong Hanlin: Awarded two EU GMP certificates

On July 3, Fosun Pharma announced on the Hong Kong Stock Exchange that its wholly-owned subsidiary, Shanghai Fosun Pharma Bio-Technology Co., Ltd., has recently received two GMP certificates from the Federal Agency for Medicines and Health Products of Belgium. The raw material production line, formulation production line, and packaging production line of HLX11, as well as the raw material production line, formulation production line, formulation line 2, formulation line 3, and packaging production line of HLX14, have all passed the GMP certification. According to the GMP mutual recognition system among EU member states, this GMP certification indicates that these production lines for HLX11 and HLX14 comply with EU GMP standards.